Radioimmunoassays

Radioimmunoassays

Global Radioimmunoassays Market to Reach US$587.1 Million by 2030

The global market for Radioimmunoassays estimated at US$470.9 Million in the year 2023, is expected to reach US$587.1 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2023-2030. Radioimmunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$458.7 Million by the end of the analysis period. Growth in the Radioimmunoassay Analyzers segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$125.6 Million While China is Forecast to Grow at 2.7% CAGR

The Radioimmunoassays market in the U.S. is estimated at US$125.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$91.7 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Radioimmunoassays Market - Key Trends and Drivers Summarized

Radioimmunoassays: Revolutionizing Diagnostic Testing

Radioimmunoassays (RIAs) are highly sensitive laboratory techniques used to measure the concentration of specific antigens or hormones in a sample, typically blood or urine. The method involves the use of radioactively labeled antigens or antibodies that bind to the target molecule, allowing for precise quantification of the substance of interest. RIAs are widely used in clinical laboratories for the detection and monitoring of various medical conditions, including hormonal disorders, infectious diseases, and cancer. The technique`s high sensitivity and specificity make it particularly valuable for detecting low levels of hormones, such as insulin, thyroid hormones, and reproductive hormones, as well as for measuring tumor markers and other biomarkers. RIAs have revolutionized diagnostic testing by providing accurate and reliable results that are critical for disease diagnosis, treatment planning, and monitoring.

How Are Technological Advancements Enhancing Radioimmunoassays?

Technological advancements have significantly improved the performance, safety, and convenience of radioimmunoassays, making them more effective for a wide range of diagnostic applications. Innovations in radioisotope labeling have enhanced the stability and sensitivity of RIA reagents, allowing for more accurate and consistent results. The development of automated RIA systems has streamlined the testing process, reducing the time and labor required for assay preparation and analysis, while also minimizing the risk of human error. Advances in assay miniaturization and the use of microplate formats have increased the throughput of RIAs, enabling the simultaneous analysis of multiple samples and improving laboratory efficiency. Additionally, the integration of RIA with other diagnostic techniques, such as enzyme immunoassays (EIAs) and chemiluminescent assays, has expanded the range of analytes that can be detected and quantified, providing more comprehensive diagnostic information. These technological improvements are driving the adoption of advanced RIA systems in clinical laboratories worldwide.

What Are the Key Applications and Benefits of Radioimmunoassays in Medical Diagnostics?

Radioimmunoassays are used in a wide range of diagnostic applications, offering numerous benefits that enhance the accuracy, reliability, and efficiency of medical testing. In endocrinology, RIAs are essential for measuring hormone levels in patients with conditions such as diabetes, thyroid disorders, and reproductive health issues, providing critical information for diagnosis and treatment planning. In oncology, RIAs are used to detect tumor markers and monitor the effectiveness of cancer therapies, allowing for early intervention and personalized treatment approaches. The technique is also valuable in infectious disease testing, where it can detect the presence of viral or bacterial antigens in patient samples, aiding in the rapid diagnosis and management of infections. Additionally, RIAs are used in pharmacokinetics to measure drug levels in the blood, ensuring appropriate dosing and monitoring therapeutic responses. The primary benefits of RIAs include their high sensitivity, specificity, and ability to detect low concentrations of analytes, making them indispensable tools in clinical diagnostics.

What Factors Are Driving the Growth in the Radioimmunoassays Market?

The growth in the Radioimmunoassays market is driven by several factors. The increasing prevalence of chronic diseases, such as cancer, diabetes, and hormonal disorders, is a significant driver, as these conditions require precise diagnostic testing for effective management. Technological advancements in radioisotope labeling, automation, and assay miniaturization are also propelling market growth by enhancing the performance and efficiency of RIA systems. The rising demand for personalized medicine and targeted therapies is further boosting the adoption of RIAs, as these techniques provide critical information for individualized treatment planning. Additionally, the expanding applications of RIAs in areas such as infectious disease testing and pharmacokinetics are contributing to market growth, as healthcare providers seek more accurate and reliable diagnostic tools. The growing focus on improving diagnostic accuracy and reducing healthcare costs is also supporting the adoption of advanced RIA systems in clinical laboratories. These factors, combined with continuous innovation in diagnostic technology, are driving the sustained growth of the Radioimmunoassays market.

 

Select Competitors (Total 44 Featured) -
  • Beckman Coulter, Inc.
  • Berthold Technologies GmbH & Co. KG
  • Cisbio Bioassays
  • DiaSorin SpA
  • Diasource Immunossays S.A
  • DRG International, Inc.
  • Euro Diagnostica AB
  • IBL International GmbH
  • Izotop
  • MilliporeSigma
  • MP Biomedicals LLC
  • PerkinElmer, Inc.
  • Stratec Biomedical AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Radioimmunoassays – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Sensitive and Specific Diagnostic Tests Propels Market Growth
Increasing Use in Clinical and Research Laboratories Expands Addressable Market Opportunity
Technological Advancements in Radioimmunoassay Techniques Strengthen Market Position
Growing Focus on Early Disease Detection and Monitoring Drives Adoption of Radioimmunoassays
Surge in Demand for Hormone and Tumor Marker Testing Generates New Opportunities
Development of Automated and High-Throughput Assay Systems Sustains Market Growth
Expanding Applications in Endocrinology and Oncology Throws Spotlight on Market Potential
Growth in Personalized Medicine and Targeted Therapies Spurs Demand for Radioimmunoassays
Rising Adoption of Radioimmunoassays in Academic and Research Institutions Propels Market Expansion
Surge in Demand for Radioimmunoassays in Infectious Disease Testing Expands Market Horizons
Growing Awareness of the Benefits of Radioimmunoassays in Rare Disease Diagnosis Drives Market Adoption
Innovations in Radioactive Labeling and Detection Technologies Generate New Market Opportunities
Rising Demand for Radioimmunoassays in Emerging Healthcare Markets Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Radioimmunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Radioimmunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Radioimmunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Radioimmunoassays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Clinical Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Clinical Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Clinical Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
JAPAN
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
CHINA
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
EUROPE
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Radioimmunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Radioimmunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Radioimmunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
FRANCE
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 77: France Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
GERMANY
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 86: Germany Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
UNITED KINGDOM
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 104: UK Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Rest of Europe 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Rest of Europe Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Rest of Europe 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Radioimmunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Asia-Pacific Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Asia-Pacific 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Asia-Pacific Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Asia-Pacific 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 131: Rest of World Recent Past, Current & Future Analysis for Radioimmunoassays by Type - Reagents & Kits and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of World Historic Review for Radioimmunoassays by Type - Reagents & Kits and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of World 16-Year Perspective for Radioimmunoassays by Type - Percentage Breakdown of Value Sales for Reagents & Kits and Analyzers for the Years 2014, 2024 & 2030
TABLE 134: Rest of World Recent Past, Current & Future Analysis for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of World Historic Review for Radioimmunoassays by End-Use - Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of World 16-Year Perspective for Radioimmunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Pharmaceutical, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 137: Rest of World Recent Past, Current & Future Analysis for Radioimmunoassays by Application - Research and Clinical Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of World Historic Review for Radioimmunoassays by Application - Research and Clinical Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of World 16-Year Perspective for Radioimmunoassays by Application - Percentage Breakdown of Value Sales for Research and Clinical Diagnostics for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings